Virtus ETF Advisers’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,277
Closed -$59.7K 433
2024
Q4
$59.7K Buy
+8,277
New +$63.2K 0.02% 452
2023
Q2
Sell
-9,389
Closed -$39.6K 440
2023
Q1
$39.6K Sell
9,389
-3,604
-28% -$42.8K 0.02% 437
2022
Q4
$214K Buy
+12,993
New +$146K 0.11% 313

Other funds holding ALT

Virtus ETF Advisers's ALT Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Altimmune (ALT) in Q1 2025, closing a stake of 8,277 shares — an estimated $59.7K sold.

Virtus ETF Advisers first reported a position in ALT in Q4 2022 and held it in 3 quarters. The position peaked at $214K in Q4 2022. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 8,277 Altimmune shares in Q1 2025, an estimated $59.7K.
  • Virtus ETF Advisers first reported a position in Altimmune in Q4 2022 and held it in 3 quarters.
  • Virtus ETF Advisers's Altimmune position peaked at $214K in Q4 2022.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.